Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.

The current COVID-19 vaccine is 33% effective at preventing emergency department or urgent care visits among adults of all ages. It also is 45% to 46% effective at preventing hospitalizations in ...

they were already planning the Phase 3 trials to evaluate whether the vaccines were effective and safe. [What you need to know about the Moderna and Pfizer coronavirus vaccines] Researchers in the ...

As the world marks the fifth anniversary of the start of the coronavirus pandemic, one question has persisted: How many lives ...

The landscape of COVID-19 prevention continues to evolve ... scientists and public health experts work to ensure that vaccines remain effective, helping to mitigate severe illness and reduce ...

“The effectiveness of the COVID vaccines can vary depending on which variants are targeted in the vaccine, which variants are circulating, and host factors,” said Shirin A. Mazumder, MD, and ...